Related Experiment Video
Updated: Aug 2, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.
1University of Texas School of Public Health, RAS Building E815, 1200 Herman Pressler, Houston, TX 77030, USA. lmoye@sph.uth.tmc.edu
Controlled Clinical Trials
|December 12, 2001
Summary
Clinical trial subgroup analyses can be complex. New methods allow for confirmatory conclusions from subgroup evaluations by prospectively defining specific criteria, enhancing trial interpretability.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Medical Research Design
Background:
- Subgroup analyses are crucial in controlled clinical trials but often complicated by issues like lack of prospective specification and inadequate sample size.
- Interpreting subgroup findings can be challenging due to potential sampling errors and power limitations.
Purpose of the Study:
- To demonstrate the availability of clinical trial design tools for drawing confirmatory conclusions from subgroup evaluations.
- To present a methodology for evaluating intervention effects within specific, prospectively defined subgroup strata.
Main Methods:
- The proposed methodology focuses on evaluating intervention effects within a particular subgroup stratum.
- It emphasizes the prespecification of stratum-specific type I error rates.
- This approach is distinct from using a treatment-by-subgroup interaction term.
Main Results:
- The methodology allows for a "stand-alone" interpretation of subgroup strata at the trial's conclusion.
- Successful interpretation requires prespecification of stratum-specific type I error rates.
- Additional factors supporting interpretation include stratum-specific event rates, primary endpoints, endpoint precision, and efficacy.
Conclusions:
- Methodologists have access to clinical trial design tools that enable confirmatory subgroup analyses.
- Prospective specification of criteria, including error rates, is key to valid subgroup interpretation.
- This approach enhances the reliability and utility of subgroup evaluations in clinical trials.
Related Concept Videos
01:13Controls in Experiments
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...